Literature DB >> 10614609

Soft-tissue reconstruction for recalcitrant diabetic foot wounds.

B K Cohen1, D D Zabel, E D Newton, A R Catanzariti.   

Abstract

Thirty-three consecutive patients with plantar soft-tissue defects were managed by a single surgeon (EDN) with reconstruction by a medial plantar artery (MPA)-based flap. Foot defects resulted from a combination of abnormal weightbearing distribution and neuropathy secondary to diabetes mellitus in all patients. A retrospective study of diabetic patients from 1984 to 1997 with foot defects reconstructed with a MPA-based flap were reviewed. Thirty-three patients (age 55 +/- 9) with an average tissue deficit of 13 +/- 9 cm2 had MPA reconstruction of the heel (n = 8), midfoot (n = 23), and forefoot (n = 2). The mean follow-up was 19 months (range, 3 months-5 years). There were four minor complications, including marginal flap necrosis or localized infection, although all healed uneventfully. There were six major complications resulting in loss of the flap and proximal amputation. Out of seven patients, there were 12 rerotations of the previously rotated flap. Various techniques for reconstruction of plantar foot defects have been described in the literature. Utilizing glabrous skin for reconstruction of these defects is appealing for its unique shear and pressure-resisting properties. Surgical management of diabetic foot defects with the medial plantar artery flap is an effective means of soft tissue reconstruction.

Entities:  

Mesh:

Year:  1999        PMID: 10614609     DOI: 10.1016/s1067-2516(99)80038-6

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  2 in total

1.  Functional reconstruction of the diabetic foot.

Authors:  Mark W Clemens; Christopher E Attinger
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

2.  The use of split-thickness skin grafts on diabetic foot ulcerations: a literature review.

Authors:  Brant McCartan; Thanh Dinh
Journal:  Plast Surg Int       Date:  2012-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.